Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 47

1.

Pentraxin 3 protects from MCMV infection and reactivation through TLR sensing pathways leading to IRF3 activation.

Bozza S, Bistoni F, Gaziano R, Pitzurra L, Zelante T, Bonifazi P, Perruccio K, Bellocchio S, Neri M, Iorio AM, Salvatori G, De Santis R, Calvitti M, Doni A, Garlanda C, Mantovani A, Romani L.

Blood. 2006 Nov 15;108(10):3387-96. Epub 2006 Jul 13.

2.

The IFN regulatory factor 7-dependent type I IFN response is not essential for early resistance against murine cytomegalovirus infection.

Steinberg C, Eisenächer K, Gross O, Reindl W, Schmitz F, Ruland J, Krug A.

Eur J Immunol. 2009 Apr;39(4):1007-18. doi: 10.1002/eji.200838814.

3.

Thymosin alpha1 activates the TLR9/MyD88/IRF7-dependent murine cytomegalovirus sensing for induction of anti-viral responses in vivo.

Bozza S, Gaziano R, Bonifazi P, Zelante T, Pitzurra L, Montagnoli C, Moretti S, Castronari R, Sinibaldi P, Rasi G, Garaci E, Bistoni F, Romani L.

Int Immunol. 2007 Nov;19(11):1261-70. Epub 2007 Sep 5.

PMID:
17804687
4.

Regulation of PTX3, a key component of humoral innate immunity in human dendritic cells: stimulation by IL-10 and inhibition by IFN-gamma.

Doni A, Michela M, Bottazzi B, Peri G, Valentino S, Polentarutti N, Garlanda C, Mantovani A.

J Leukoc Biol. 2006 Apr;79(4):797-802. Epub 2006 Feb 3.

PMID:
16461742
5.

PTX3 binds MD-2 and promotes TRIF-dependent immune protection in aspergillosis.

Bozza S, Campo S, Arseni B, Inforzato A, Ragnar L, Bottazzi B, Mantovani A, Moretti S, Oikonomous V, De Santis R, Carvalho A, Salvatori G, Romani L.

J Immunol. 2014 Sep 1;193(5):2340-8. doi: 10.4049/jimmunol.1400814. Epub 2014 Jul 21.

6.

Ncf1 provides a reactive oxygen species-independent negative feedback regulation of TLR9-induced IL-12p70 in murine dendritic cells.

Richter C, Juan MH, Will J, Brandes RP, Kalinke U, Akira S, Pfeilschifter JM, Hultqvist M, Holmdahl R, Radeke HH.

J Immunol. 2009 Apr 1;182(7):4183-91. doi: 10.4049/jimmunol.0800795.

7.

Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.

Sawaki J, Tsutsui H, Hayashi N, Yasuda K, Akira S, Tanizawa T, Nakanishi K.

Int Immunol. 2007 Mar;19(3):311-20. Epub 2007 Feb 7.

PMID:
17289654
8.

Interferon-regulatory-factor 1 controls Toll-like receptor 9-mediated IFN-beta production in myeloid dendritic cells.

Schmitz F, Heit A, Guggemoos S, Krug A, Mages J, Schiemann M, Adler H, Drexler I, Haas T, Lang R, Wagner H.

Eur J Immunol. 2007 Feb;37(2):315-27.

9.

TLR9 cooperates with TLR4 to increase IL-12 release by murine dendritic cells.

Theiner G, Rössner S, Dalpke A, Bode K, Berger T, Gessner A, Lutz MB.

Mol Immunol. 2008 Jan;45(1):244-52. Epub 2007 Jun 27.

PMID:
17599410
10.

Evidence for licensing of IFN-gamma-induced IFN regulatory factor 1 transcription factor by MyD88 in Toll-like receptor-dependent gene induction program.

Negishi H, Fujita Y, Yanai H, Sakaguchi S, Ouyang X, Shinohara M, Takayanagi H, Ohba Y, Taniguchi T, Honda K.

Proc Natl Acad Sci U S A. 2006 Oct 10;103(41):15136-41. Epub 2006 Oct 3.

11.

Toll-like receptor-dependent and -independent viperin gene expression and counter-regulation by PRDI-binding factor-1/BLIMP1.

Severa M, Coccia EM, Fitzgerald KA.

J Biol Chem. 2006 Sep 8;281(36):26188-95. Epub 2006 Jul 18.

12.

Toll-like receptor-dependent activation of antigen-presenting cells affects adaptive immunity to Helicobacter pylori.

Rad R, Brenner L, Krug A, Voland P, Mages J, Lang R, Schwendy S, Reindl W, Dossumbekova A, Ballhorn W, Wagner H, Schmid RM, Bauer S, Prinz C.

Gastroenterology. 2007 Jul;133(1):150-163.e3. Epub 2007 May 3.

PMID:
17631139
13.

Positive regulation of plasmacytoid dendritic cell function via Ly49Q recognition of class I MHC.

Tai LH, Goulet ML, Belanger S, Toyama-Sorimachi N, Fodil-Cornu N, Vidal SM, Troke AD, McVicar DW, Makrigiannis AP.

J Exp Med. 2008 Dec 22;205(13):3187-99. doi: 10.1084/jem.20080718. Epub 2008 Dec 15.

14.

Conventional Dendritic Cells Confer Protection against Mouse Cytomegalovirus Infection via TLR9 and MyD88 Signaling.

Puttur F, Francozo M, Solmaz G, Bueno C, Lindenberg M, Gohmert M, Swallow M, Tufa D, Jacobs R, Lienenklaus S, Kühl AA, Borkner L, Cicin-Sain L, Holzmann B, Wagner H, Berod L, Sparwasser T.

Cell Rep. 2016 Oct 18;17(4):1113-1127. doi: 10.1016/j.celrep.2016.09.055.

15.

Hepatitis C virus nonstructural protein 5A modulates the toll-like receptor-MyD88-dependent signaling pathway in macrophage cell lines.

Abe T, Kaname Y, Hamamoto I, Tsuda Y, Wen X, Taguwa S, Moriishi K, Takeuchi O, Kawai T, Kanto T, Hayashi N, Akira S, Matsuura Y.

J Virol. 2007 Sep;81(17):8953-66. Epub 2007 Jun 13.

17.

The long pentraxin PTX3 in vascular pathology.

Mantovani A, Garlanda C, Bottazzi B, Peri G, Doni A, Martinez de la Torre Y, Latini R.

Vascul Pharmacol. 2006 Nov;45(5):326-30. Epub 2006 Aug 23. Review.

PMID:
17023219
18.

Exogenous pentraxin 3 restores antifungal resistance and restrains inflammation in murine chronic granulomatous disease.

D'Angelo C, De Luca A, Zelante T, Bonifazi P, Moretti S, Giovannini G, Iannitti RG, Zagarella S, Bozza S, Campo S, Salvatori G, Romani L.

J Immunol. 2009 Oct 1;183(7):4609-18. doi: 10.4049/jimmunol.0900345. Epub 2009 Sep 4.

19.

Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids.

Paget C, Mallevaey T, Speak AO, Torres D, Fontaine J, Sheehan KC, Capron M, Ryffel B, Faveeuw C, Leite de Moraes M, Platt F, Trottein F.

Immunity. 2007 Oct;27(4):597-609. Epub 2007 Oct 18.

20.

TNF receptor independent activation of the cytomegalovirus major immediate early enhancer in response to transplantation.

Zhang Z, Kim SJ, Varghese T, Thomas G, Hummel M, Abecassis M.

Transplantation. 2008 Apr 15;85(7):1039-45. doi: 10.1097/TP.0b013e318168449c.

PMID:
18408586

Supplemental Content

Support Center